Warp Sciences Inc. — SEC Form D Filing
Warp Sciences Inc. filed an SEC Form D on October 23, 2026, reporting $194.61M raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 23, 2026
- Amount reported
- $194.61M
- Round stage
- Series A
- Industry
- Biotechnology
- Website
- https://warp.xyz/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Drug discovery relies on slow, repetitive experimental cycles that can take years and thousands of compounds to yield a promising candidate. Furthermore, foundational chemistry has largely shifted overseas and remains heavily dependent on manual labor.
Solution
Warp is a U.S.-based chemistry contract research organization (CRO) that combines expert chemists, AI, and robotics in automated laboratories to synthesize molecules and speed up drug discovery.
Why now
Advances in laboratory robotics and foundation AI models make high-throughput automated synthesis feasible, coinciding with geopolitical and supply chain incentives to bring critical drug discovery capabilities back to the United States.
Source: SEC EDGAR Form D filing